Abstract:Jiaqian Wang, 1 Yuan Xue, 2 Liang Zhou 3 1 Department of Orthopaedic, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China; 2 Department of Orthopaedic, Wuxi Ninth People's Hospital of Soochow University, Wuxi, 214000, People's Republic of China; 3 Department of Orthopaedic, Lianshui County People's Hospital, Huai'an, People's Republic of China Correspondence: Jiaqian Wang, Email Background: Rheumatoid arthritis (RA) is a chronic systemic immune disease characterized by joint synovitis, but there are differences in clinical manifestations and serum test results among different patients. Methods: This is a bioinformatics study. We first obtained the gene expression profile of RA and normal synovium from the database, and screened the differentially expressed immune related genes for enrichment analysis. Subsequently, we classified RA into three subtypes by unsupervised clustering of serum gene expression profiles based on immune enrichment scores. Then, the enrichment and clinical characteristics of different subtypes were analyzed. Finally, according to the infiltration of different subtypes of immune cells, diagnostic markers were screened and verified by qRT-PCR. Results: C1 subtype is related to the increase of neutrophils, C-reactive protein and erythrocyte sedimentation rate, and joint pain is more significant in patients. C2 subtype is related to the expression of CD8+T cells and Tregs, and patients have mild joint pain symptoms. The RF value of C3 subtype is higher, and the expression of various immune cells is increased. CD4 T cells, NK cells activated, macrophages M1 and neutrophils are immune cells significantly infiltrated in synovium and serum of RA patients. IFNGR1, TRAC, IFITM1 can be used as diagnostic markers of different subtypes. Conclusion: In this study, RA patients were divided into different immune molecular subtypes based on gene expression profile, and immune diagnostic markers were screened, which provided a new idea for the diagnosis and treatment of RA. Keywords: rheumatoid arthritis, molecular subtype, immune cells, immunodiagnostic markers Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by joint synovitis. Persistent synovitis can lead to irreversible damage of intra-articular cartilage and bone, joint dysfunction, and even disability. 1 The Global Burden of Disease research report showed that the prevalence of RA increased by 7.4% and the incidence rate increased by 8.2% between 1990 and 2017. 2 However, the exact cause of RA has not yet been clarified, environmental, infectious, genetic and other factors are closely related. 3 Among them, it is widely recognized that immune factors play a crucial role in the whole process. 4 Studies have shown that the infiltration of immune cells in synovium seriously affects the occurrence and progression of RA. 5 For example, macrophages can secrete a large number of cytokines, chemokines and degrading enzymes, which are positively correlated with the severity of the disease. 6 Activated CD4+T cells can initiate specific immune responses, leading to joint inflammation and bone destruction. 7 Other immune cells, such as natural killer cells, also play a regulatory role in RA. 8 Therefore, it is very important to evaluate the infiltration of immune cells in synovium and determine the differences of immune cell components in order to clarify the pathogenesis of RA. In addition, although the basic pathological change of RA is synovitis, some patients show alternate onset and relief of joint pain, while others show persistent swelling and joint pain, with almost no relief process. 9 Even some patients have extra-articular manifestations, with 14.7% of patients developing interstitial lung disease. 10 Therefore, early diagnosis and classification of RA is of great significance for the treatment of RA. 11 However, the current role of serological diagnostic markers is limited. Even if rheumatoid factor and anti-cyclic citrulline antibody are positive, RA cannot be diagnosed, and it still needs to be based on long-term clinical symptoms. 12 C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) increased in the acute stage of RA, but there was no specificity. 13 This brings great difficulties to the early diagnosis of RA, but the first change in RA patients is usually at the molecular level. 14 With the development and widespread use of microarray and high-throughput sequencing technology, we can early identify changes in gene expression and screen out immune diagnostic markers. 15 Fo -Abstract Truncated-

Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition

A compendium of mitochondrial molecular characteristics provides novel perspectives on the treatment of rheumatoid arthritis patients

[A Cross-Sectional Study on the Clinical Phenotypes of Rheumatoid Arthritis].

From molecular subgroups to molecular targeted therapy in rheumatoid arthritis: A bioinformatics approach

OP0184 PHENOTYPING OF MOLECULAR SIGNATURES IN THE SYNOVIAL TISSUE OF RHEUMATOID ARTHRITIS BY INTEGRATIVE SYSTEMS ANALYSIS

Integrated analysis of single-cell RNA-seq, bulk RNA-seq, Mendelian randomization, and eQTL reveals T cell-related nomogram model and subtype classification in rheumatoid arthritis

New Classification of Rheumatoid Arthritis Based on Immune Cells and Clinical Characteristics

Identification of clinical characteristics biomarkers for rheumatoid arthritis through targeted DNA methylation sequencing

The shared biomarkers and immune landscape in psoriatic arthritis and rheumatoid arthritis: Findings based on bioinformatics, machine learning and single-cell analysis

Analyzation of the Peripheral Blood Mononuclear Cells Atlas and Cell Communication of Rheumatoid Arthritis Patients Based on Single-Cell RNA-Seq

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness

Identification of diagnostic biomarkers of rheumatoid arthritis based on machine learning-assisted comprehensive bioinformatics and its correlation with immune cells

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Rheumatoid Arthritis by Bioinformatics Analysis

Predicting best treatment in rheumatoid arthritis

Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and RNA Sequencing Data

Identification and Validation of Hub Genes for Predicting Treatment Targets and Immune Landscape in Rheumatoid Arthritis

Inference of an Integrative, Executable Network for Rheumatoid Arthritis Combining Data-Driven Machine Learning Approaches and a State-of-the-Art Mechanistic Disease Map

Single-cell RNA-Seq analysis reveals cell subsets and gene signatures associated with rheumatoid arthritis disease activity

Identification of Diagnostic Signatures and Immune Cell Infiltration Characteristics in Rheumatoid Arthritis by Integrating Bioinformatic Analysis and Machine-Learning Strategies

Identification and preliminary validation of synovial tissue-specific genes and their-mediated biological mechanisms in rheumatoid arthritis

Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis